Summary

The landscape of single-use injection devices in Europe has seen remarkable growth as healthcare systems focus more on patient safety and infection control. These devices came into widespread use to address the risks associated with reusable syringes, which often led to contamination and the spread of infections. Before their introduction, healthcare workers and patients faced challenges like needle-stick injuries and the difficulty of proper sterilization, which made treatment riskier and less efficient. To overcome these problems, manufacturers developed various designs including safety-engineered syringes and prefilled versions that ensure sterile conditions and reduce handling errors. Hospitals, clinics, and vaccination programs widely use these devices to deliver precise doses safely and hygienically. The utilization of these syringes has surged significantly as the epidemic of AIDS has nearly eradicated the habit of reusing needles. Technically, they consist of a barrel, plunger, and needle assembly made from medical-grade materials that guarantee sterility until use. The predominant material for disposable syringes is injection-molded polypropylene. Syringes consist of two or three components and are available in sizes of 1 ml, 2 ml, 5 ml, and 10 ml. The single-use nature prevents any chance of cross-contamination and allows quick disposal, making them highly effective in clinical settings. Over time, advances in polymer technology and manufacturing precision have improved their durability and comfort during injection. Research teams continue to innovate by introducing features like retractable needles and protective shields that activate automatically after use, significantly reducing injury risks. Companies also invest in automated production lines and quality control systems to maintain high standards and meet strict European regulations. Additionally, some manufacturers are exploring eco-friendly materials to reduce environmental impact.

According to the research report "Europe Disposable Syringes Market Outlook, 2030," published by Bonafide Research, the Europe Disposable Syringes market is anticipated to grow at more than 6.42% CAGR from 2025 to 2030. This rise comes mainly from heightened awareness about patient safety and stricter regulations aimed at reducing infections and accidental needle injuries. Another key factor boosting growth is the rise in chronic diseases requiring regular injections and expanded vaccination drives in many countries. Recently, companies have launched syringes with improved safety features such as retractable needles and anti-slip designs to make administration easier and safer for both healthcare workers and patients. Major suppliers like Becton Dickinson, Terumo Europe, and Nipro focus on offering a broad range of syringes, including conventional, safety, and prefilled types to meet diverse clinical needs. These firms invest in research and development to enhance usability and compliance with medical standards. For instance, by 2030, biologics are expected to comprise over 30% of pharmaceutical sales, driving demand for prefilled syringes that ensure sterility, dosing accuracy, and ease of use. In May 2023, SCHOTT Pharma, located in Germany, introduced pre-fillable syringes (PFS) designed for deep-cold pharmaceuticals, capable of being stored and delivered on dry ice at temperatures as low as -100°C. Consequently, due to the introduction of sophisticated pre-fillable syringes by leading manufacturers, this market is expected to have significant increase throughout the projected period. Their compatibility with injectable biologics makes them vital for delivering high-value therapies in areas like oncology, immunology, and chronic disease management. The region offers significant growth opportunities, especially in outpatient and homecare settings, where demand for easy-to-use and safer injection tools is rising. Strict health regulations require products to meet European Medicines Agency and CE marking standards, which ensure safety and performance quality.


Market Drivers

? Strong Regulatory Push for Needle Safety and Infection Control:The European Union enforces strict safety regulations under directives such as the EU Sharps Directive (2010/32/EU), which mandates the use of safety-engineered syringes in healthcare settings. This regulatory environment drives hospitals and clinics across Europe to adopt auto-disable and retractable syringes. It increases demand for safety-compliant products and leads to long-term supply contracts for manufacturers. Companies benefit by producing premium-priced syringes tailored to regulatory norms, which encourages local manufacturing and technology upgrades. Expanding Geriatric Population with Higher Healthcare Dependency:Europe has one of the oldest populations globally, particularly in countries like Germany, Italy, and France. Older individuals often require injectable treatments for conditions like diabetes, osteoporosis, cardiovascular disorders, and arthritis. This demographic shift creates a stable and growing demand for disposable syringes, especially in long-term care and outpatient settings. It helps manufacturers streamline production planning, increase automation, and develop user-friendly syringe designs.

Market Challenges

? Stringent Environmental Regulations on Medical Waste Disposal:The European Green Deal and national waste directives enforce high standards for managing medical and plastic waste. This places pressure on healthcare providers and syringe manufacturers to reduce their environmental footprint. The need to adopt recyclable or biodegradable materials adds complexity to product design and increases production costs. Disposal challenges impact hospital procurement budgets and slow the adoption of standard disposable syringes. For manufacturers, this leads to increased compliance costs and R&D investments, while consumers may face higher prices or limited availability of low-cost syringes.
? Complex and Fragmented Public Procurement Systems:Europe’s healthcare system is largely public-funded but decentralized, with each country and even regions within countries operating distinct procurement processes. This fragmentation creates challenges for syringe suppliers trying to enter multiple markets across the EU. Companies face delays due to lengthy tendering processes, country-specific certifications, and pricing pressures. Producers struggle with inconsistent demand forecasting and regulatory variations, while hospitals may face procurement bottlenecks.

Market Trends

? Shift Toward Eco-friendly Syringes and Circular Manufacturing Models:Driven by EU sustainability goals, there is growing interest in eco-friendly syringes made from biodegradable plastics or recyclable materials. Consumers and institutions prefer products with reduced carbon footprints. This trend influences public tenders and institutional buyers to prioritize green-certified syringes. Manufacturers invest in sustainable materials and waste-minimization technologies, contributing to a circular economy. The shift aligns healthcare with broader climate goals, supports green jobs, and promotes local sourcing strategies across the supply chain.
? Growth in Cross-border Vaccine and Therapeutic Logistics:Europe sees high syringe demand linked to coordinated EU-wide vaccine campaigns, including cross-border logistics managed by the European Medicines Agency and ECDC. This integrated model requires high volumes of pre-sterilized disposable syringes ready for distribution to multiple countries. Consumers benefit from rapid access to injections during public health drives. Manufacturers increase output capacity and leverage regional warehouses, boosting intra-European trade. The trend supports economies of scale, strengthens pharma-logistics networks, and increases regional self-sufficiency in medical supplies.


Safety syringes are the fastest growing type in the Europe disposable syringes market due to stringent regulations and strong emphasis on healthcare worker safety that drive widespread adoption of safer injection devices.

Safety syringes come with built-in features that protect users from accidental needle-stick injuries and prevent reuse, which lowers the risk of transmitting bloodborne infections such as hepatitis and HIV. In Europe, regulatory bodies like the European Medicines Agency (EMA) and country-specific health authorities enforce strict guidelines on needle safety, pushing healthcare providers to use safety-engineered syringes to comply with these rules. The European Union’s Directive 2010/32/EU specifically mandates measures to prevent sharps injuries, fueling demand for safety syringes across hospitals, clinics, and diagnostic labs. Companies such as Becton Dickinson, Terumo, and Nipro supply innovative safety syringes with retractable needles, protective shields, and automatic locking systems that are gaining popularity among healthcare professionals. These manufacturers frequently participate in medical trade shows like MEDICA and campaigns to raise awareness about the benefits of safety syringes in reducing workplace injuries. The shift towards safety syringes also helps healthcare institutions lower costs associated with needlestick injuries, such as treatment expenses and legal liabilities. Moreover, rising vaccination programs and an aging population requiring injectable treatments increase the volume of syringes used, further encouraging adoption of safer products. The ease of disposal and improved infection control make safety syringes a preferred choice. Continuous advancements in syringe technology, combined with healthcare workers’ preference for safer, user-friendly devices, support steady market growth.

Therapeutic injections lead the Europe disposable syringes market because of the growing number of chronic diseases and the increasing use of injectable biologic drugs requiring safe and precise delivery.

Therapeutic injections involve administering medication directly into the body to manage ongoing health conditions such as diabetes, cancer, rheumatoid arthritis, and multiple sclerosis. In Europe, the prevalence of chronic diseases continues to rise due to aging populations and lifestyle changes, leading to a higher need for injectable therapies. Pharmaceutical companies and medical device manufacturers, including Becton Dickinson, Terumo, and Gerresheimer, offer a range of disposable syringes designed to deliver biologics and other injectable drugs accurately and safely. These firms invest in developing prefilled syringes and autoinjectors that enhance convenience for both healthcare providers and patients. The rise in home healthcare and self-administration trends also contributes to increased demand, as patients prefer easy-to-use injection devices that allow them to manage their treatment independently. Companies promote these products through healthcare conferences such as the European Society of Medical Oncology (ESMO) and various pharma exhibitions, highlighting their benefits like precise dosing, reduced contamination risks, and improved patient comfort. Regulatory bodies such as the European Medicines Agency (EMA) ensure that disposable syringes meet stringent safety and quality standards, which adds to market confidence. The cost-efficiency of disposable syringes combined with their role in improving treatment adherence supports their growing use in therapeutic applications. Healthcare systems across Europe encourage safe and effective drug delivery methods to reduce hospital stays and complications.

The pharmaceutical industry (B2B) segment, especially for prefilled syringes, is the fastest growing end user in Europe because drug manufacturers increasingly adopt ready-to-use delivery systems to improve safety, efficiency, and patient compliance.

Prefilled syringes are medical devices preloaded with a specific dose of medication, ready for immediate use. In Europe, pharmaceutical companies prefer these syringes as they reduce the risk of contamination, dosing errors, and drug wastage, which is crucial when handling expensive biologics and vaccines. Leading suppliers such as Becton Dickinson, Gerresheimer, and West Pharmaceutical Services provide advanced prefilled syringe systems that pharmaceutical companies integrate with injectable drugs to meet regulatory demands and patient needs. These companies actively participate in medical conferences like CPhI Europe and MedTech Forum, showcasing innovations in syringe technology, including features like needle safety shields, improved silicone coatings to protect drug integrity, and ergonomic designs that ease self-administration. Prefilled syringes simplify drug delivery for healthcare providers and patients by reducing preparation time and ensuring precise dosing, which improves treatment outcomes and lowers the risk of infection. The growth of self-injectable therapies for chronic diseases such as multiple sclerosis, rheumatoid arthritis, and diabetes drives demand for these products. Furthermore, stringent European regulations require high standards for drug delivery devices, encouraging pharmaceutical companies to invest in prefilled syringe technology to meet compliance and quality benchmarks. The rise in vaccination campaigns and biologic drug approvals also supports rapid adoption. Prefilled syringes help pharmaceutical firms enhance their market competitiveness by offering convenient, safe, and effective drug delivery options.


Germany leads the Europe disposable syringes market because it has a strong domestic manufacturing base, highly developed healthcare infrastructure, and a high frequency of medical procedures that rely on sterile single-use syringes.

Germany has built a highly efficient and quality-driven healthcare system that uses large volumes of disposable syringes for both preventive and therapeutic medical needs. The country performs a high number of clinical procedures, including outpatient treatments, surgeries, vaccinations, and chronic disease management, all of which require disposable syringes for safety, hygiene, and convenience. Public and private hospitals in Germany follow strict infection control protocols under European Union Medical Device Regulations (EU MDR) and guidelines from the Robert Koch Institute, which reinforce the use of single-use medical instruments like syringes. Germany also acts as a key manufacturing hub for medical technology in Europe, with several global and domestic firms such as B. Braun, Gerresheimer, and SCHOTT operating advanced production units for medical disposables including syringes, needle systems, and prefilled injection components. These companies benefit from high domestic demand, favorable regulatory alignment, and access to precision engineering, which allows them to scale efficiently and meet both domestic and export requirements. The healthcare sector in Germany is publicly funded through statutory insurance, which ensures access to quality medical supplies for the majority of the population and reduces out-of-pocket spending, allowing hospitals to consistently procure sterile syringes without budget constraints. Germany’s central location in Europe also makes it a critical distribution point for medical supplies across EU countries, strengthening its position in the market. Moreover, the country’s quick response during public health emergencies, such as large-scale COVID-19 vaccination rollouts and flu immunization programs, further boosts syringe usage.




Considered in this report
? Historic Year: 2019
? Base year: 2024
? Estimated year: 2025
? Forecast year: 2030

Aspects covered in this report
? Disposable Syringes Market with its value and forecast along with its segments
? Various drivers and challenges
? On-going trends and developments
? Top profiled companies
? Strategic recommendation

By Type
? Conventional Syringes
? Safety Syringes

By Application
? Immunization Injections
? Therapeutic Injections

By End User
? Hospitals
? Diagnostic Laboratories
? Blood Banks
? Others (Pharmaceutical Industry (B2B) (Prefilled Syringes))

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analyzing the government generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources.

Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to this industry, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.


***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents

Table of Content

1. Executive Summary
2. Market Dynamics
2.1. Market Drivers & Opportunities
2.2. Market Restraints & Challenges
2.3. Market Trends
2.3.1. XXXX
2.3.2. XXXX
2.3.3. XXXX
2.3.4. XXXX
2.3.5. XXXX
2.4. Supply chain Analysis
2.5. Policy & Regulatory Framework
2.6. Industry Experts Views
3. Research Methodology
3.1. Secondary Research
3.2. Primary Data Collection
3.3. Market Formation & Validation
3.4. Report Writing, Quality Check & Delivery
4. Market Structure
4.1. Market Considerate
4.2. Assumptions
4.3. Limitations
4.4. Abbreviations
4.5. Sources
4.6. Definitions
5. Economic /Demographic Snapshot
6. Europe Disposable Syringes Market Outlook
6.1. Market Size By Value
6.2. Market Share By Country
6.3. Market Size and Forecast, By Type
6.4. Market Size and Forecast, By Application
6.5. Market Size and Forecast, By End User
6.6. Germany Disposable Syringes Market Outlook
6.6.1. Market Size by Value
6.6.2. Market Size and Forecast By Type
6.6.3. Market Size and Forecast By Application
6.6.4. Market Size and Forecast By End User
6.7. United Kingdom (UK) Disposable Syringes Market Outlook
6.7.1. Market Size by Value
6.7.2. Market Size and Forecast By Type
6.7.3. Market Size and Forecast By Application
6.7.4. Market Size and Forecast By End User
6.8. France Disposable Syringes Market Outlook
6.8.1. Market Size by Value
6.8.2. Market Size and Forecast By Type
6.8.3. Market Size and Forecast By Application
6.8.4. Market Size and Forecast By End User
6.9. Italy Disposable Syringes Market Outlook
6.9.1. Market Size by Value
6.9.2. Market Size and Forecast By Type
6.9.3. Market Size and Forecast By Application
6.9.4. Market Size and Forecast By End User
6.10. Spain Disposable Syringes Market Outlook
6.10.1. Market Size by Value
6.10.2. Market Size and Forecast By Type
6.10.3. Market Size and Forecast By Application
6.10.4. Market Size and Forecast By End User
6.11. Russia Disposable Syringes Market Outlook
6.11.1. Market Size by Value
6.11.2. Market Size and Forecast By Type
6.11.3. Market Size and Forecast By Application
6.11.4. Market Size and Forecast By End User
7. Competitive Landscape
7.1. Competitive Dashboard
7.2. Business Strategies Adopted by Key Players
7.3. Key Players Market Positioning Matrix
7.4. Porter's Five Forces
7.5. Company Profile
7.5.1. B. Braun Melsungen SE
7.5.1.1. Company Snapshot
7.5.1.2. Company Overview
7.5.1.3. Financial Highlights
7.5.1.4. Geographic Insights
7.5.1.5. Business Segment & Performance
7.5.1.6. Product Portfolio
7.5.1.7. Key Executives
7.5.1.8. Strategic Moves & Developments
7.5.2. Becton, Dickinson and Company
7.5.3. Nipro Corporation
7.5.4. Terumo Corporation
7.5.5. Cardinal Health Inc.
7.5.6. Fresenius SE & Co. KGaA
7.5.7. Agilent Technologies, Inc.
7.5.8. Henke-Sass Wolf GmbH
7.5.9. Cole-Parmer Instrument Company, LLC
7.5.10. Narang Medical Limited
7.5.11. Thermo Fisher Scientific Inc.
7.5.12. SCHOTT AG
8. Strategic Recommendations
9. Annexure
9.1. FAQ`s
9.2. Notes
9.3. Related Reports
10. Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Figures

Figure 1: Global Disposable Syringes Market Size (USD Billion) By Region, 2024 & 2030
Figure 2: Market attractiveness Index, By Region 2030
Figure 3: Market attractiveness Index, By Segment 2030
Figure 4: Europe Disposable Syringes Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 5: Europe Disposable Syringes Market Share By Country (2024)
Figure 6: Germany Disposable Syringes Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 7: United Kingdom (UK) Disposable Syringes Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 8: France Disposable Syringes Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 9: Italy Disposable Syringes Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 10: Spain Disposable Syringes Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 11: Russia Disposable Syringes Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
Figure 12: Porter's Five Forces of Global Disposable Syringes Market


List of Tables

Table 1: Global Disposable Syringes Market Snapshot, By Segmentation (2024 & 2030) (in USD Billion)
Table 2: Influencing Factors for Disposable Syringes Market, 2024
Table 3: Top 10 Counties Economic Snapshot 2022
Table 4: Economic Snapshot of Other Prominent Countries 2022
Table 5: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 6: Europe Disposable Syringes Market Size and Forecast, By Type (2019 to 2030F) (In USD Billion)
Table 7: Europe Disposable Syringes Market Size and Forecast, By Application (2019 to 2030F) (In USD Billion)
Table 8: Europe Disposable Syringes Market Size and Forecast, By End User (2019 to 2030F) (In USD Billion)
Table 9: Germany Disposable Syringes Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 10: Germany Disposable Syringes Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 11: Germany Disposable Syringes Market Size and Forecast By End User (2019 to 2030F) (In USD Billion)
Table 12: United Kingdom (UK) Disposable Syringes Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 13: United Kingdom (UK) Disposable Syringes Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 14: United Kingdom (UK) Disposable Syringes Market Size and Forecast By End User (2019 to 2030F) (In USD Billion)
Table 15: France Disposable Syringes Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 16: France Disposable Syringes Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 17: France Disposable Syringes Market Size and Forecast By End User (2019 to 2030F) (In USD Billion)
Table 18: Italy Disposable Syringes Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 19: Italy Disposable Syringes Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 20: Italy Disposable Syringes Market Size and Forecast By End User (2019 to 2030F) (In USD Billion)
Table 21: Spain Disposable Syringes Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 22: Spain Disposable Syringes Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 23: Spain Disposable Syringes Market Size and Forecast By End User (2019 to 2030F) (In USD Billion)
Table 24: Russia Disposable Syringes Market Size and Forecast By Type (2019 to 2030F) (In USD Billion)
Table 25: Russia Disposable Syringes Market Size and Forecast By Application (2019 to 2030F) (In USD Billion)
Table 26: Russia Disposable Syringes Market Size and Forecast By End User (2019 to 2030F) (In USD Billion)
Table 27: Competitive Dashboard of top 5 players, 2024